APPROVED USE

IHEEZO™ is indicated for ocular surface anesthesia

IMPORTANT SAFETY INFORMATION

IHEEZO is contraindicated in patients with a history of
hypersensitivity to any component of this preparation.

IHEEZO should not be injected or intraocularly administered.

Patients should not touch the eye for at least 10 to 20 minutes
after using anesthetic as accidental injuries can occur
due to insensitivity of the eye.

Prolonged use of a topical ocular anesthetic may produce permanent
corneal opacification and ulceration with accompanying visual loss.

Do not touch the dropper tip to any surface as this may
contaminate the gel. IHEEZO is indicated for administration
under the direct supervision of a healthcare provider. IHEEZO
is not intended for patient self-administration.

The most common adverse reactions in studies following
IHEEZO administration, (incidence greater than or equal to 5%)
were mydriasis, conjunctival hyperemia, and eye irritation.

You are encouraged to report suspected adverse reactions to
the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For the Full Prescribing Information for IHEEZO, please Click here.